Literature DB >> 36094735

KDM3A promotes oral squamous cell carcinoma cell proliferation and invasion via H3K9me2 demethylation-activated DCLK1.

Lei Yang1, Qiqiong Zhang2, Qiuye Yang2.   

Abstract

BACKGROUND: Oral squamous cell carcinoma (OSCC) is a frequently-diagnosed malignancy with high potential for proliferation and invasion. Histone methylation is known as a crucial mechanism that regulates pathological processes in various cancers, including OSCC.
OBJECTIVE: This study sought to delve into the molecular mechanism of lysine demethylase 3 A (KDM3A) in OSCC cell proliferation and invasion.
METHODS: Expression levels of KDM3A, lysin-9 of di-methylated histone H3 (H3K9me2), and doublecortin-like kinase 1 (DCLK1) in cells were determined by reverse-transcription quantitative polymerase chain reaction or Western blot analysis. Cell proliferation and invasion were evaluated by cell counting kit-8, colony formation, and Transwell assays. The enrichment of KDM3A and H3K9me2 on the DCLK1 promoter was determined by chromatin immunoprecipitation assay. The functional rescue experiment was performed with DCLK1 overexpression vector and si-KDM3A in CAL-27 and SCC-9 cells.
RESULTS: KDM3A was elevated in OSCC cells. KDM3A knockdown suppressed OSCC proliferation and invasion, along with increased H3K9me2 level in OSCC cells. KDM3A and H3K9me2 were enriched on the DCLK1 promoter and inhibiting H3K9me2 improved DCLK1 expression levels. DCLK1 overexpression neutralized the inhibition of KDM3A knockdown on OSCC proliferation and invasion.
CONCLUSIONS: KDM3A facilitated OSCC proliferation and invasion by eliminating H3K9me2 to upregulate DCLK1 expression levels.
© 2022. The Author(s) under exclusive licence to The Genetics Society of Korea.

Entities:  

Keywords:  DCLK1; H3K9me2; Invasion; KDM3A; Oral squamous cell carcinoma; Proliferation

Mesh:

Substances:

Year:  2022        PMID: 36094735     DOI: 10.1007/s13258-022-01287-0

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   2.164


  1 in total

1.  DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment.

Authors:  Chiman Mohammadi; Ali Mahdavinezhad; Massoud Saidijam; Fatemeh Bahreini; Abdolazim Sedighi Pashaki; Mohammad Hadi Gholami; Rezvan Najafi
Journal:  Int J Mol Cell Med       Date:  2021-05-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.